SHILPAMED Relative Valuation - Shilpa Medicare Ltd - Alpha Spread

Shilpa Medicare Ltd
NSE:SHILPAMED

Watchlist Manager
Shilpa Medicare Ltd Logo
Shilpa Medicare Ltd
NSE:SHILPAMED
Watchlist
Price: 802.3 INR -0.42% Market Closed
Market Cap: 78.5B INR
Have any thoughts about
Shilpa Medicare Ltd?
Write Note

Relative Value

The Relative Value of one SHILPAMED stock under the Base Case scenario is 759.9 INR. Compared to the current market price of 802.3 INR, Shilpa Medicare Ltd is Overvalued by 5%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

SHILPAMED Relative Value
Base Case
759.9 INR
Overvaluation 5%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
1
vs Industry
23
Median 3Y
3.5
Median 5Y
3.9
Industry
2.6
Forward
5
vs History
6
vs Industry
1
Median 3Y
100.1
Median 5Y
28.6
Industry
22.9
Forward
48.7
vs History
22
vs Industry
8
Median 3Y
35.5
Median 5Y
36.8
Industry
17.6
vs History
6
vs Industry
3
Median 3Y
2.3
Median 5Y
11.9
Industry
25.2
vs History
1
vs Industry
22
Median 3Y
2.2
Median 5Y
2.4
Industry
2.2
vs History
1
vs Industry
21
Median 3Y
3.7
Median 5Y
4.2
Industry
2.7
Forward
5.4
vs History
1
vs Industry
21
Median 3Y
6
Median 5Y
6.5
Industry
5.4
vs History
14
vs Industry
12
Median 3Y
24
Median 5Y
23
Industry
13.9
Forward
21.6
vs History
30
vs Industry
8
Median 3Y
51.7
Median 5Y
39.3
Industry
17.3
Forward
41
vs History
22
vs Industry
8
Median 3Y
39
Median 5Y
39.7
Industry
16.1
vs History
vs Industry
Median 3Y
-54
Median 5Y
-55.9
Industry
18.8
vs History
3
vs Industry
33
Median 3Y
1.6
Median 5Y
1.8
Industry
2

Multiples Across Competitors

SHILPAMED Competitors Multiples
Shilpa Medicare Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
IN
Shilpa Medicare Ltd
NSE:SHILPAMED
78.5B INR 6.6 175.3 31.1 51.8
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
843.2B USD 21.7 114.8 57.4 64.3
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.4T DKK 13.3 38.2 25.5 29.2
US
Johnson & Johnson
NYSE:JNJ
385.8B USD 4.5 10.1 12.4 16.1
US
Merck & Co Inc
NYSE:MRK
278.3B USD 4.5 20.3 13.7 16.8
CH
Roche Holding AG
SIX:ROG
206.1B CHF 3.5 17.9 10.1 12
UK
AstraZeneca PLC
NASDAQ:AZN
240.2B USD 4.9 37.3 17.1 25.6
CH
Novartis AG
SIX:NOVN
191.2B CHF 4.6 13.8 10.9 16.1
US
Pfizer Inc
NYSE:PFE
162B USD 2.9 -62.4 12.6 20.4
P/E Multiple
Earnings Growth
IN
Shilpa Medicare Ltd
NSE:SHILPAMED
Average P/E: 53.5
175.3
N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
114.8
425%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
38.2
90%
US
Johnson & Johnson
NYSE:JNJ
10.1
-22%
US
Merck & Co Inc
NYSE:MRK
20.3
7 419%
CH
Roche Holding AG
SIX:ROG
17.9
30%
UK
A
AstraZeneca PLC
NASDAQ:AZN
37.3
175%
CH
Novartis AG
SIX:NOVN
13.8
19%
US
Pfizer Inc
NYSE:PFE
Negative Multiple: -62.4
712%

See Also

Discover More
Back to Top